000 01564 a2200409 4500
005 20250515073004.0
264 0 _c20071212
008 200712s 0 0 eng d
022 _a0269-2813
024 7 _a10.1111/j.1365-2036.2007.03361.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSandborn, W J
245 0 0 _aMMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cJul 2007
300 _a205-15 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xtherapeutic use
650 0 4 _aColitis, Ulcerative
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMesalamine
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRemission Induction
650 0 4 _aSeverity of Illness Index
700 1 _aKamm, M A
700 1 _aLichtenstein, G R
700 1 _aLyne, A
700 1 _aButler, T
700 1 _aJoseph, R E
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 26
_gno. 2
_gp. 205-15
856 4 0 _uhttps://doi.org/10.1111/j.1365-2036.2007.03361.x
_zAvailable from publisher's website
999 _c17129968
_d17129968